Quest Diagnostics Profit Margin 2010-2025 | DGX

Current and historical gross margin, operating margin and net profit margin for Quest Diagnostics (DGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Quest Diagnostics net profit margin as of March 31, 2025 is 8.81%.
Quest Diagnostics Annual Profit Margins
Quest Diagnostics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.132B $9.872B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Encompass Health (EHC) United States $12.047B 25.54
DaVita (DVA) United States $10.318B 14.51
Chemed (CHE) United States $8.383B 26.34
Elanco Animal Health (ELAN) United States $6.655B 14.26
Option Care Health (OPCH) United States $5.197B 23.17
RadNet (RDNT) United States $4.148B 263.29
Amedisys (AMED) United States $3.072B 20.66
LifeStance Health (LFST) United States $2.349B 0.00
Addus HomeCare (ADUS) United States $2.084B 22.88
Astrana Health (ASTH) United States $1.380B 34.18
U.S Physical Therapy (USPH) United States $1.146B 29.58
Aveanna Healthcare Holdings (AVAH) United States $1.034B 58.89
Pennant (PNTG) United States $0.960B 35.27
Atai Life Sciences (ATAI) Germany $0.463B 0.00
Daxor (DXR) United States $0.039B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00